Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Bioorganic & Medicinal Chemistry Letters
|
May 8, 2021
Exploring boron applications in modern agriculture: A structure-activity relationship study of a novel series of multi-substitution benzoxaboroles for identification of potential fungicides
Chunliang Liu, Luke Steere, Cari McGregor, et al.
Journal of Medicinal Chemistry
|
June 13, 2018
Detailed Exploration around 4-Aminoquinolines Chemical Space to Navigate the Lysine Methyltransferase G9a and DNA Methyltransferase Biological Spaces
Obdulia Rabal, Juan Antonio Sánchez-Arias, Edurne San José-Enériz, et al.
Journal of Medicinal Chemistry
|
March 4, 2021
Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with <i>In Vivo</i> Efficacy in Multiple Myeloma
Obdulia Rabal, Edurne San José-Enériz, Xabier Agirre, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 25, 2017
Identification of a 4-fluorobenzyl l-valinate amide benzoxaborole (AN11736) as a potential development candidate for the treatment of Animal African Trypanosomiasis (AAT)
Tsutomu Akama, Yong-Kang Zhang, Yvonne R Freund, et al.
ACS Chemical Neuroscience
|
August 24, 2019
Multitarget Approach for the Treatment of Alzheimer's Disease: Inhibition of Phosphodiesterase 9 (PDE9) and Histone Deacetylases (HDACs) Covering Diverse Selectivity Profiles
Obdulia Rabal, Juan A Sánchez-Arias, Mar Cuadrado-Tejedor, et al.
Journal of Medicinal Chemistry
|
June 29, 2018
Discovery of Reversible DNA Methyltransferase and Lysine Methyltransferase G9a Inhibitors with Antitumoral in Vivo Efficacy
Obdulia Rabal, Edurne San José-Enériz, Xabier Agirre, et al.
Journal of Medicinal Chemistry
|
March 21, 2024
Discovery of DNL343: A Potent, Selective, and Brain-Penetrant eIF2B Activator Designed for the Treatment of Neurodegenerative Diseases
Robert A Craig, Javier De Vicente, Anthony A Estrada, et al.
Journal of Medicinal Chemistry
|
December 5, 2022
Discovery of Potent and Selective Dual Leucine Zipper Kinase/Leucine Zipper-Bearing Kinase Inhibitors with Neuroprotective Properties in In Vitro and In Vivo Models of Amyotrophic Lateral Sclerosis
Robert A Craig, Brian M Fox, Cheng Hu, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Bioorganic & Medicinal Chemistry Letters
|
May 8, 2021
Exploring boron applications in modern agriculture: A structure-activity relationship study of a novel series of multi-substitution benzoxaboroles for identification of potential fungicides
Chunliang Liu, Luke Steere, Cari McGregor, et al.
Journal of Medicinal Chemistry
|
June 13, 2018
Detailed Exploration around 4-Aminoquinolines Chemical Space to Navigate the Lysine Methyltransferase G9a and DNA Methyltransferase Biological Spaces
Obdulia Rabal, Juan Antonio Sánchez-Arias, Edurne San José-Enériz, et al.
Journal of Medicinal Chemistry
|
March 4, 2021
Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with <i>In Vivo</i> Efficacy in Multiple Myeloma
Obdulia Rabal, Edurne San José-Enériz, Xabier Agirre, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 25, 2017
Identification of a 4-fluorobenzyl l-valinate amide benzoxaborole (AN11736) as a potential development candidate for the treatment of Animal African Trypanosomiasis (AAT)
Tsutomu Akama, Yong-Kang Zhang, Yvonne R Freund, et al.
ACS Chemical Neuroscience
|
August 24, 2019
Multitarget Approach for the Treatment of Alzheimer's Disease: Inhibition of Phosphodiesterase 9 (PDE9) and Histone Deacetylases (HDACs) Covering Diverse Selectivity Profiles
Obdulia Rabal, Juan A Sánchez-Arias, Mar Cuadrado-Tejedor, et al.
Journal of Medicinal Chemistry
|
June 29, 2018
Discovery of Reversible DNA Methyltransferase and Lysine Methyltransferase G9a Inhibitors with Antitumoral in Vivo Efficacy
Obdulia Rabal, Edurne San José-Enériz, Xabier Agirre, et al.
Journal of Medicinal Chemistry
|
March 21, 2024
Discovery of DNL343: A Potent, Selective, and Brain-Penetrant eIF2B Activator Designed for the Treatment of Neurodegenerative Diseases
Robert A Craig, Javier De Vicente, Anthony A Estrada, et al.
Journal of Medicinal Chemistry
|
December 5, 2022
Discovery of Potent and Selective Dual Leucine Zipper Kinase/Leucine Zipper-Bearing Kinase Inhibitors with Neuroprotective Properties in In Vitro and In Vivo Models of Amyotrophic Lateral Sclerosis
Robert A Craig, Brian M Fox, Cheng Hu, et al.
Page
of 2